Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years
Clinical trial NCT06281119 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06281119
- Sponsor
- Serum Institute of India Pvt. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-03
- Primary completion
- 2026-12-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.